The partners will conduct an exploratory study to determine how the results of Exagen's lupus test impacts primary care physician practice referral patterns.
Lab, diagnostic and healthcare groups want Congress to enact legislation to modify PAMA and address concerns about the way CMS collected data and established test prices.
